Table 3: Comparison of Hcy levels in NMO patients with different disease activity, gender, NMO-IgG seropositivity and occurrence of relapse
NMO
Hcy (µmol/L)
P
Active
9.7 ± 4.1
0.818
Inactive
9.8 ± 3.3
Female
9.5 ± 3.1
0.385
Male
11.0 ± 5.6
NMO-IgG positive
9.7 ± 3.6
0.95
NMO-IgG negative
9.8 ± 3.9
Relapse
9.3 ± 3.3
0.067
No relapse
11.3 ± 4.6
Abbreviations: Hcy: Homocysteine; NMO: Neuromyelitis Optica